{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:57:03Z","timestamp":1782410223757,"version":"3.54.5"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007374","name":"UFMG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007374","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010674","name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Nano-biofarmac\u00eautica","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010674","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["CBB-APQ-00496-11"],"award-info":[{"award-number":["CBB-APQ-00496-11"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["CBB-APQ-00819-12"],"award-info":[{"award-number":["CBB-APQ-00819-12"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-472090\/2011-9"],"award-info":[{"award-number":["APQ-472090\/2011-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["RHAE-456287\/2012-4"],"award-info":[{"award-number":["RHAE-456287\/2012-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-482976\/2012-8"],"award-info":[{"award-number":["APQ-482976\/2012-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["APQ-488237\/2013-0"],"award-info":[{"award-number":["APQ-488237\/2013-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.exppara.2015.03.027","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T05:55:31Z","timestamp":1428299731000},"page":"180-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis"],"prefix":"10.1016","volume":"153","author":[{"given":"Nath\u00e1lia Cristina","family":"de Jesus Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiliam C\u00e9sar Bento","family":"R\u00e9gis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourena Emanuele","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil Silvano","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna Gomes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Tamietti","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Costa","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Roberto Rodrigues","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Sousa","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica Santos","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Norma","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Aguiar","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto Pereira","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Antonio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2015.03.027_bib0010","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1128\/IAI.61.7.2952-2959.1993","article-title":"Immune responses associated with susceptibility of C57BL\/10 mice to Leishmania amazonensis","volume":"61","author":"Afonso","year":"1993","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.03.027_bib0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nprot.2007.102","article-title":"Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent","volume":"2","author":"Ainsworth","year":"2007","journal-title":"Nat. Protoc"},{"key":"10.1016\/j.exppara.2015.03.027_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1099\/00222615-23-4-363","article-title":"Effect of glucan on Leishmania major infection in BALB\/c mice","volume":"23","author":"Al Tuwaijri","year":"1987","journal-title":"J. Med. Microbiol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"issue":"Suppl. 2","key":"10.1016\/j.exppara.2015.03.027_bib0030","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/BF01973598","article-title":"Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral leishmaniasis","volume":"13","author":"Badar\u00f3","year":"1994","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis"},{"key":"10.1016\/j.exppara.2015.03.027_bib0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-3083.2005.01667.x","article-title":"An extract of the mushroom Agaricus blazei Murill administered orally protects against systemic Streptococcus pneumoniae infection in mice","volume":"62","author":"Bernardshaw","year":"2005","journal-title":"Scand. J. Immunol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0040","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10529-005-0222-6","article-title":"Structural characterization of beta-glucans of Agaricus brasiliensis in different stages of fruiting body maturity and their use in nutraceutical products","volume":"27","author":"Camelini","year":"2005","journal-title":"Biotechnol. Lett"},{"key":"10.1016\/j.exppara.2015.03.027_bib0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carri\u00f3n","year":"2006","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.actatropica.2007.08.007","article-title":"Successful vaccination against Leishmania chagasi infection in BALB\/c mice with freeze-thaw Leishmania antigen and Corynabacterium parvum","volume":"104","author":"Carvalho","year":"2007","journal-title":"Acta Trop"},{"key":"10.1016\/j.exppara.2015.03.027_bib0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12026-013-8400-4","article-title":"Adverse events following immunization with vaccines containing adjuvants","volume":"56","author":"Cerpa-Cruz","year":"2013","journal-title":"Immunol. Res"},{"key":"10.1016\/j.exppara.2015.03.027_bib0060","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.micinf.2010.06.008","article-title":"Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB\/c mice against Leishmania chagasi and Leishmania amazonensis challenge","volume":"12","author":"Ch\u00e1vez-Fumagalli","year":"2010","journal-title":"Microbes Infect"},{"key":"10.1016\/j.exppara.2015.03.027_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vetimm.2005.08.028","article-title":"Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease","volume":"109","author":"Chen","year":"2006","journal-title":"Vet. Immunol. Immunopathol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0070","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.03.027_bib0075","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.03.027_bib0080","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/IAI.37.3.1261-1269.1982","article-title":"Protective effect of glucan against visceral leishmaniasis in protective effect of glucan against visceral leishmaniasis in hamsters","volume":"37","author":"Cook","year":"1982","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.03.027_bib0085","article-title":"Vaccines for the leishmaniases: proposals for a research agenda","volume":"5","author":"Costa","year":"2011","journal-title":"PLoS Negl. Trop. Dis"},{"key":"10.1016\/j.exppara.2015.03.027_bib0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/CVI.00583-13","article-title":"Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications","volume":"21","author":"Costa","year":"2014","journal-title":"Clin. Vaccine Immunol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0095","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis: current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0100","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3892\/ol.2013.1484","article-title":"A polysaccharide isolated from Agaricus blazei Murill (ABP-AW1) as a potential Th1 immunity-stimulating adjuvant","volume":"6","author":"Cui","year":"2013","journal-title":"Oncol. Lett"},{"key":"10.1016\/j.exppara.2015.03.027_bib0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-2427(87)90135-8","article-title":"Adjuvants","volume":"17","author":"Dalsgaard","year":"1987","journal-title":"Vet. Immunol. Immunopathol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0110","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ac60111a017","article-title":"Colorimetric method for determination of sugars and related substances","volume":"28","author":"Dubois","year":"1956","journal-title":"Anal. Chem"},{"key":"10.1016\/j.exppara.2015.03.027_bib0115","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1128\/IAI.71.11.6499-6509.2003","article-title":"Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice","volume":"71","author":"Dumas","year":"2003","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.03.027_bib0120","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.imbio.2013.05.001","article-title":"Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant","volume":"218","author":"Engel","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.exppara.2015.03.027_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"Fernandes","year":"2012","journal-title":"Curr. Opin. Microbiol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0130","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.vaccine.2013.12.046","article-title":"Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis","volume":"32","author":"Fernandes","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.03.027_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2051013613480144","article-title":"Working together: interactions between vaccine antigens and adjuvants","volume":"1","author":"Fox","year":"2013","journal-title":"Ther. Adv. Vaccines"},{"key":"10.1016\/j.exppara.2015.03.027_bib0140","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1016\/j.vaccine.2007.08.009","article-title":"Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs","volume":"25","author":"Giunchetti","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.03.027_bib0145","first-page":"S45","article-title":"National cooperative vaccine development working group. Safety evaluation of vaccine adjuvants","volume":"9","author":"Goldenthal","year":"1993","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.exppara.2015.03.027_bib0150","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00394-011-0270-8","article-title":"Pro-inflammatory effects of the mushroom Agaricus blazei and its consequences on atherosclerosis development","volume":"51","author":"Gon\u00e7alves","year":"2012","journal-title":"Eur. J. Nutr"},{"key":"10.1016\/j.exppara.2015.03.027_bib0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin. Microbiol. Rev"},{"key":"10.1016\/j.exppara.2015.03.027_bib0160","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4269\/ajtmh.1981.30.762","article-title":"Immunization against Leishmania donovani: glucan as an adjuvant with killed promastigotes","volume":"30","author":"Holbrook","year":"1981","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"10.1016\/j.exppara.2015.03.027_bib0165","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.4049\/jimmunol.142.12.4441","article-title":"Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen\/liposomes. Optimization and assessment of the requirement for intravenous immunization","volume":"142","author":"Kahl","year":"1989","journal-title":"J. Immunol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0170","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.146.2.431","article-title":"Separation and characterization of saponins with adjuvant activity from Quillaja-saponaria molina cortex","volume":"146","author":"Kensil","year":"1991","journal-title":"J. Immunol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0175","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/S0264-410X(98)00084-X","article-title":"Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine","volume":"16","author":"Koike","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.03.027_bib0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4269\/ajtmh.2012.10-0415","article-title":"The economic value of a visceral leishmaniasis vaccine in Bihar state, India","volume":"86","author":"Lee","year":"2012","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"10.1016\/j.exppara.2015.03.027_bib0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/107999000312748","article-title":"The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice","volume":"20","author":"Lehmann","year":"2000","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1016\/j.exppara.2015.03.027_bib0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.exppara.2015.03.027_bib0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00595-011-0075-7","article-title":"Biological mechanism and clinical effect of protein-bound polysaccharide K (Krestin\u00ae): review of development and future perspectives","volume":"42","author":"Maehara","year":"2012","journal-title":"Surg. Today"},{"key":"10.1016\/j.exppara.2015.03.027_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/427655ac-c278-41f5-95ca-6279c562752f","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Negl. Trop. Dis"},{"key":"10.1016\/j.exppara.2015.03.027_bib0205","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijbiomac.2008.06.008","article-title":"Protective effect of polysaccharides from Morinda officinalis on bone loss in ovariectomized rats","volume":"43","author":"Meng","year":"2008","journal-title":"Int. J. Biol. Macromol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0210","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2010","journal-title":"Travel Med. Infect. Dis"},{"key":"10.1016\/j.exppara.2015.03.027_bib0215","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/S0264-410X(01)00058-5","article-title":"Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG","volume":"19","author":"Misra","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.03.027_bib0220","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T","article-title":"IL-10 mediates susceptibility to Leishmania donovani infection","volume":"31","author":"Murphy","year":"2001","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0225","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI117767","article-title":"Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis","volume":"95","author":"Murray","year":"1995","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.exppara.2015.03.027_bib0230","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.03.027_bib0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0192-0561(89)90159-8","article-title":"Protective effect of L.\u2009donovani antigens using glucan as an adjuvant","volume":"11","author":"Obaid","year":"1989","journal-title":"Int. J. Immunopharmacol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0240","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2009.02.009","article-title":"The path to a successful vaccine adjuvant: \u201cthe long and winding road\u201d","volume":"14","author":"O'Hagan","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.exppara.2015.03.027_bib0245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.exppara.2015.03.027_bib0250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2174\/0929867003374705","article-title":"Immunomodulation and anti-cancer activity of polysaccharide-protein complexes","volume":"7","author":"Ooi","year":"2000","journal-title":"Curr. Med. Chem"},{"key":"10.1016\/j.exppara.2015.03.027_bib0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0147-9571(00)00026-6","article-title":"Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes","volume":"24","author":"Panaro","year":"2001","journal-title":"Comp. Immunol. Microbiol. Infect. Dis"},{"key":"10.1016\/j.exppara.2015.03.027_bib0260","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.vaccine.2006.11.057","article-title":"Safety trial using the Leishmune\u00ae vaccine against canine visceral leishmaniasis in Brazil","volume":"25","author":"Parra","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.03.027_bib0265","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0270","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/erv.11.30","article-title":"Carbohydrate-based immune adjuvants","volume":"10","author":"Petrovsky","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.exppara.2015.03.027_bib0275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0021-9258(18)72984-0","article-title":"Anticomplementary factor in fresh yeast","volume":"137","author":"Pillemer","year":"1941","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.exppara.2015.03.027_bib0280","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","article-title":"Adjuvant effects of saponins on animal immune responses","volume":"8","author":"Rajput","year":"2007","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.exppara.2015.03.027_bib0285","first-page":"3","article-title":"Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis","volume":"7","author":"Ram\u00edrez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.exppara.2015.03.027_bib0290","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-3305-7-3","article-title":"Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis","volume":"7","author":"Ram\u00edrez","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.exppara.2015.03.027_bib0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/CLEP.S44267","article-title":"Epidemiology of visceral leishmaniasis","volume":"6","author":"Ready","year":"2014","journal-title":"Clin. Epidemiol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0300","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med"},{"key":"10.1016\/j.exppara.2015.03.027_bib0305","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/IAI.67.8.3719-3726.1999","article-title":"Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major","volume":"67","author":"Stacey","year":"1999","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.03.027_bib0310","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/IAI.72.10.5654-5661.2004","article-title":"Immunization with Leishmania major exogenous antigens protects susceptible BALB\/c mice against challenge infection with Leishmania major","volume":"72","author":"Tonui","year":"2004","journal-title":"Infect. Immun"},{"key":"10.1016\/j.exppara.2015.03.027_bib0315","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.parint.2011.06.001","article-title":"Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species","volume":"60","author":"Valadares","year":"2011","journal-title":"Parasitol. Intern"},{"key":"10.1016\/j.exppara.2015.03.027_bib0320","first-page":"1","article-title":"Therapeutic efficacy induced by the oral administration of Agaricus blazei Murill against Leishmania amazonensis","volume":"113","author":"Valadares","year":"2012","journal-title":"Parasitol. Res"},{"key":"10.1016\/j.exppara.2015.03.027_bib0325","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.exppara.2012.07.005","article-title":"Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis","volume":"132","author":"Valadares","year":"2012","journal-title":"Exp. Parasitol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0330","article-title":"beta-Glucan oligosaccharide enhances CD8(+) T cells immune response induced by a DNA vaccine encoding hepatitis B virus core antigen","volume":"645213","author":"Wang","year":"2010","journal-title":"J. Biomed. Biotechnol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0335","author":"World Health Organization"},{"key":"10.1016\/j.exppara.2015.03.027_bib0340","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3347\/kjp.2009.47.4.345","article-title":"Aureobasidium-derived soluble branched (1,3-1,6) beta-glucan (Sophy beta-glucan) enhances natural killer activity in Leishmania amazonensis-infected mice","volume":"47","author":"Yatawara","year":"2009","journal-title":"Korean J. Parasitol"},{"key":"10.1016\/j.exppara.2015.03.027_bib0345","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.micinf.2007.05.012","article-title":"Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections","volume":"9","author":"Zanin","year":"2007","journal-title":"Microbes Infect"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415000892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415000892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T06:47:44Z","timestamp":1691563664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489415000892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":68,"alternative-id":["S0014489415000892"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2015.03.027","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2015.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}